Literature DB >> 22219275

SIRT1 protects against α-synuclein aggregation by activating molecular chaperones.

Gizem Donmez1, Anirudh Arun, Chee-Yeun Chung, Pamela J McLean, Susan Lindquist, Leonard Guarente.   

Abstract

α-Synuclein is a key molecule in the pathogenesis of synucleinopathy including dementia with Lewy bodies, Parkinson's disease, and multiple system atrophy. Sirtuins are NAD(+)-dependent protein deacetylases that are highly conserved and counter aging in lower organisms. We show that the life span of a mouse model with A53T α-synuclein mutation is increased by overexpressing SIRT1 and decreased by knocking out SIRT1 in brain. Furthermore, α-synuclein aggregates are reduced in the brains of mice with SIRT1 overexpression and increased by SIRT1 deletion. We show that SIRT1 deacetylates HSF1 (heat shock factor 1) and increases HSP70 RNA and protein levels, but only in the brains of mice with A53T and SIRT1 expression. Thus, SIRT1 responds to α-synuclein aggregation-induced stress by activating molecular chaperones to protect against disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219275      PMCID: PMC3263206          DOI: 10.1523/JNEUROSCI.3442-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

1.  Parkinson disease survival: a population-based study.

Authors:  L Morgante; G Salemi; F Meneghini; A E Di Rosa; A Epifanio; F Grigoletto; P Ragonese; F Patti; A Reggio; R Di Perri; G Savettieri
Journal:  Arch Neurol       Date:  2000-04

2.  Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction.

Authors:  Dena E Cohen; Andrea M Supinski; Michael S Bonkowski; Gizem Donmez; Leonard P Guarente
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

3.  Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.

Authors:  K Arima; K Uéda; N Sunohara; S Hirai; Y Izumiyama; H Tonozuka-Uehara; M Kawai
Journal:  Brain Res       Date:  1998-10-12       Impact factor: 3.252

4.  The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy.

Authors:  Derya R Shimshek; Matthias Mueller; Christoph Wiessner; Tatjana Schweizer; P Herman van der Putten
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

Review 5.  Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

Authors:  Kumlesh K Dev; Katja Hofele; Samuel Barbieri; Vladimir L Buchman; Herman van der Putten
Journal:  Neuropharmacology       Date:  2003-07       Impact factor: 5.250

6.  The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide.

Authors:  Diego Albani; Letizia Polito; Sara Batelli; Stefania De Mauro; Claudia Fracasso; Giuliana Martelli; Laura Colombo; Claudia Manzoni; Mario Salmona; Silvio Caccia; Alessandro Negro; Gianluigi Forloni
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

7.  Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.

Authors:  Hyunkyung Jeong; Dena E Cohen; Libin Cui; Andrea Supinski; Jeffrey N Savas; Joseph R Mazzulli; John R Yates; Laura Bordone; Leonard Guarente; Dimitri Krainc
Journal:  Nat Med       Date:  2011-12-18       Impact factor: 53.440

8.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

9.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

10.  Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity.

Authors:  Esti Yeger-Lotem; Laura Riva; Linhui Julie Su; Aaron D Gitler; Anil G Cashikar; Oliver D King; Pavan K Auluck; Melissa L Geddie; Julie S Valastyan; David R Karger; Susan Lindquist; Ernest Fraenkel
Journal:  Nat Genet       Date:  2009-02-22       Impact factor: 38.330

View more
  86 in total

1.  Scrapie infection in experimental rodents and SMB-S15 cells decreased the brain endogenous levels and activities of Sirt1.

Authors:  Jing Wang; Jin Zhang; Qi Shi; Bao-Yun Zhang; Cao Chen; Li-Na Chen; Jing Sun; Hui Wang; Kang Xiao; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2014-11-13       Impact factor: 3.444

Review 2.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

3.  Heat shock and caloric restriction have a synergistic effect on the heat shock response in a sir2.1-dependent manner in Caenorhabditis elegans.

Authors:  Rachel Raynes; Bruce D Leckey; Kevin Nguyen; Sandy D Westerheide
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

4.  Stress Inducibility of SIRT1 and Its Role in Cytoprotection and Cancer.

Authors:  Rachel Raynes; Jessica Brunquell; Sandy D Westerheide
Journal:  Genes Cancer       Date:  2013-03

Review 5.  Expanding proteostasis by membrane trafficking networks.

Authors:  Darren M Hutt; William E Balch
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

6.  Targeting sirtuin-1 in Huntington's disease: rationale and current status.

Authors:  Wenzhen Duan
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 7.  SIRT1 regulation modulates stroke outcome.

Authors:  Valérie Petegnief; Anna M Planas
Journal:  Transl Stroke Res       Date:  2013-08-15       Impact factor: 6.829

Review 8.  The sirtuin family's role in aging and age-associated pathologies.

Authors:  Jessica A Hall; John E Dominy; Yoonjin Lee; Pere Puigserver
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 9.  Brain activation of SIRT1: role in neuropathology.

Authors:  Alanna Fernandes Paraíso; Keila Lopes Mendes; Sergio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2013-04-25       Impact factor: 5.590

10.  Genetic association of sirtuin genes and Parkinson's disease.

Authors:  Silvia Jesús; Pilar Gómez-Garre; Fátima Carrillo; María T Cáceres-Redondo; Ismael Huertas-Fernández; Inmaculada Bernal-Bernal; Marta Bonilla-Toribio; Laura Vargas-González; Manuel Carballo; Pablo Mir
Journal:  J Neurol       Date:  2013-05-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.